Cargando…
Life-threatening asthma attack during prolonged fingolimod treatment: case report
BACKGROUND: Fingolimod (FTY) mediates bronchoconstriction by interacting with sphingosine-1-phosphate receptors. The majority of the reported adverse respiratory events occur during the first weeks of treatment. CASE PRESENTATION: A 49-year-old woman developed a life-threatening asthma attack after...
Autores principales: | Zecca, Chiara, Caporro, Matteo, Györik, Sandor, Gobbi, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105229/ https://www.ncbi.nlm.nih.gov/pubmed/25053881 http://dx.doi.org/10.2147/PPA.S65708 |
Ejemplares similares
-
Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing–remitting multiple sclerosis treatment
por: Caporro, Matteo, et al.
Publicado: (2014) -
Factors for poor prognosis of near-fatal asthma after recovery from a life-threatening asthma attack
por: Kim, Myung-Shin, et al.
Publicado: (2008) -
Anti-interleukin-5 therapy (mepolizumab) in life-threatening asthma attack: A case-based discussion
por: Tello, Khodr, et al.
Publicado: (2019) -
A Case-control Study of Asthma Death and Life-threatening Attack: Their Possible Relationship with Prescribed Drug Therapy in Japan
por: Tanihara, Shinichi, et al.
Publicado: (2007) -
Urinanalysis (UA): a neglected but easy and inexpensive diagnostic tool
por: Györik, Sándor, et al.
Publicado: (2009)